APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mouse Monoclonal Antibody Production Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mouse Monoclonal Antibody Production Service Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchMouse Monoclonal Antibody Production Service Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Mouse Monoclonal Antibody Production Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Mouse Monoclonal Antibody Production Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mouse Monoclonal Antibody Production Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Mouse Monoclonal Antibody Production Service Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Mouse Monoclonal Antibody Production Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mouse Monoclonal Antibody Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mouse Monoclonal Antibody Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mouse Monoclonal Antibody Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mouse Monoclonal Antibody Production Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mouse Monoclonal Antibody Production Service market include Thermo Fisher Scientific, GenScript, Sino Biological, ProMab, Sydlabs, Rockland Immunochemicals, Inc, Boster Bio, Antibodies Incorporated and Creative Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Mouse Monoclonal Antibody Production Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mouse Monoclonal Antibody Production Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mouse Monoclonal Antibody Production Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Mouse Monoclonal Antibody Production Service market.

Mouse Monoclonal Antibody Production Service Segment by Company

Thermo Fisher Scientific

GenScript

Sino Biological

ProMab

Sydlabs

Rockland Immunochemicals, Inc

Boster Bio

Antibodies Incorporated

Creative Diagnostics

Synaptic Systems

Inotiv Bioproducts

ProSpec

Applied Biological Materials Inc. (abm)

Creative Biolabs

Abvigen

R&D Systems

Eurogentec

Mouse Monoclonal Antibody Production Service Segment by Type

Hybridoma Technology

Phage Display Technology

Single B Cell Cloning Technology

Mouse Monoclonal Antibody Production Service Segment by Application

Biomedical Research

Diagnostics

Others

Mouse Monoclonal Antibody Production Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mouse Monoclonal Antibody Production Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Mouse Monoclonal Antibody Production Service key companies, revenue, market share, and recent developments.

3. To split the Mouse Monoclonal Antibody Production Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Mouse Monoclonal Antibody Production Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mouse Monoclonal Antibody Production Service significant trends, drivers, influence factors in global and regions.

6. To analyze Mouse Monoclonal Antibody Production Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mouse Monoclonal Antibody Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mouse Monoclonal Antibody Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mouse Monoclonal Antibody Production Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mouse Monoclonal Antibody Production Service industry.

Chapter 3: Detailed analysis of Mouse Monoclonal Antibody Production Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Mouse Monoclonal Antibody Production Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Mouse Monoclonal Antibody Production Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mouse Monoclonal Antibody Production Service Industry Trends Table 2. Mouse Monoclonal Antibody Production Service Industry Drivers Table 3. Mouse Monoclonal Antibody Production Service Industry Opportunities and Challenges Table 4. Mouse Monoclonal Antibody Production Service Industry Restraints Table 5. Global Mouse Monoclonal Antibody Production Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mouse Monoclonal Antibody Production Service Revenue Share by Company (2021-2026) Table 7. Global Mouse Monoclonal Antibody Production Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Mouse Monoclonal Antibody Production Service Key Company Manufacturing Base & Headquarters Table 9. Global Mouse Monoclonal Antibody Production Service Company, Product Type & Application Table 10. Global Mouse Monoclonal Antibody Production Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Mouse Monoclonal Antibody Production Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hybridoma Technology Table 15. Significant Companies of Phage Display Technology Table 16. Significant Companies of Single B Cell Cloning Technology Table 17. Global Mouse Monoclonal Antibody Production Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Mouse Monoclonal Antibody Production Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Mouse Monoclonal Antibody Production Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Mouse Monoclonal Antibody Production Service Sales Value Share by Type (2021-2026) Table 21. Global Mouse Monoclonal Antibody Production Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Biomedical Research Table 23. Significant Companies of Diagnostics Table 24. Significant Companies of Others Table 25. Global Mouse Monoclonal Antibody Production Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Mouse Monoclonal Antibody Production Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Mouse Monoclonal Antibody Production Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Mouse Monoclonal Antibody Production Service Sales Value Share by Application (2021-2026) Table 29. Global Mouse Monoclonal Antibody Production Service Sales Value Share by Application (2027-2032) Table 30. Global Mouse Monoclonal Antibody Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Mouse Monoclonal Antibody Production Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Mouse Monoclonal Antibody Production Service Sales Value Share by Region (2021-2026) Table 33. Global Mouse Monoclonal Antibody Production Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Mouse Monoclonal Antibody Production Service Sales Value Share by Region (2027-2032) Table 35. Global Mouse Monoclonal Antibody Production Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Mouse Monoclonal Antibody Production Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Mouse Monoclonal Antibody Production Service Sales Value Market Share by Country (2021-2026) Table 38. Global Mouse Monoclonal Antibody Production Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Mouse Monoclonal Antibody Production Service Sales Value Market Share by Country (2027-2032) Table 40. Thermo Fisher Scientific Company Information Table 41. Thermo Fisher Scientific Business Overview Table 42. Thermo Fisher Scientific Mouse Monoclonal Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Thermo Fisher Scientific Mouse Monoclonal Antibody Production Service Product Portfolio Table 44. Thermo Fisher Scientific Recent Development Table 45. GenScript Company Information Table 46. GenScript Business Overview Table 47. GenScript Mouse Monoclonal Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. GenScript Mouse Monoclonal Antibody Production Service Product Portfolio Table 49. GenScript Recent Development Table 50. Sino Biological Company Information Table 51. Sino Biological Business Overview Table 52. Sino Biological Mouse Monoclonal Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Sino Biological Mouse Monoclonal Antibody Production Service Product Portfolio Table 54. Sino Biological Recent Development Table 55. ProMab Company Information Table 56. ProMab Business Overview Table 57. ProMab Mouse Monoclonal Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. ProMab Mouse Monoclonal Antibody Production Service Product Portfolio Table 59. ProMab Recent Development Table 60. Sydlabs Company Information Table 61. Sydlabs Business Overview Table 62. Sydlabs Mouse Monoclonal Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Sydlabs Mouse Monoclonal Antibody Production Service Product Portfolio Table 64. Sydlabs Recent Development Table 65. Rockland Immunochemicals, Inc Company Information Table 66. Rockland Immunochemicals, Inc Business Overview Table 67. Rockland Immunochemicals, Inc Mouse Monoclonal Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Rockland Immunochemicals, Inc Mouse Monoclonal Antibody Production Service Product Portfolio Table 69. Rockland Immunochemicals, Inc Recent Development Table 70. Boster Bio Company Information Table 71. Boster Bio Business Overview Table 72. Boster Bio Mouse Monoclonal Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Boster Bio Mouse Monoclonal Antibody Production Service Product Portfolio Table 74. Boster Bio Recent Development Table 75. Antibodies Incorporated Company Information Table 76. Antibodies Incorporated Business Overview Table 77. Antibodies Incorporated Mouse Monoclonal Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Antibodies Incorporated Mouse Monoclonal Antibody Production Service Product Portfolio Table 79. Antibodies Incorporated Recent Development Table 80. Creative Diagnostics Company Information Table 81. Creative Diagnostics Business Overview Table 82. Creative Diagnostics Mouse Monoclonal Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Creative Diagnostics Mouse Monoclonal Antibody Production Service Product Portfolio Table 84. Creative Diagnostics Recent Development Table 85. Synaptic Systems Company Information Table 86. Synaptic Systems Business Overview Table 87. Synaptic Systems Mouse Monoclonal Antibody Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Synaptic Systems Mouse Monoclonal Antibody Production Service Product Portfolio Table 89. Synaptic Systems Recent Development Table 90. Inotiv Bioproducts Company Information Table 91. Inotiv Bioproducts Business Overview Table 92. Inotiv Bioproducts Mouse Monoclonal Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Inotiv Bioproducts Mouse Monoclonal Antibody Production Service Product Portfolio Table 94. Inotiv Bioproducts Recent Development Table 95. ProSpec Company Information Table 96. ProSpec Business Overview Table 97. ProSpec Mouse Monoclonal Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. ProSpec Mouse Monoclonal Antibody Production Service Product Portfolio Table 99. ProSpec Recent Development Table 100. Applied Biological Materials Inc. (abm) Company Information Table 101. Applied Biological Materials Inc. (abm) Business Overview Table 102. Applied Biological Materials Inc. (abm) Mouse Monoclonal Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Applied Biological Materials Inc. (abm) Mouse Monoclonal Antibody Production Service Product Portfolio Table 104. Applied Biological Materials Inc. (abm) Recent Development Table 105. Creative Biolabs Company Information Table 106. Creative Biolabs Business Overview Table 107. Creative Biolabs Mouse Monoclonal Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Creative Biolabs Mouse Monoclonal Antibody Production Service Product Portfolio Table 109. Creative Biolabs Recent Development Table 110. Abvigen Company Information Table 111. Abvigen Business Overview Table 112. Abvigen Mouse Monoclonal Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Abvigen Mouse Monoclonal Antibody Production Service Product Portfolio Table 114. Abvigen Recent Development Table 115. R&D Systems Company Information Table 116. R&D Systems Business Overview Table 117. R&D Systems Mouse Monoclonal Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. R&D Systems Mouse Monoclonal Antibody Production Service Product Portfolio Table 119. R&D Systems Recent Development Table 120. Eurogentec Company Information Table 121. Eurogentec Business Overview Table 122. Eurogentec Mouse Monoclonal Antibody Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Eurogentec Mouse Monoclonal Antibody Production Service Product Portfolio Table 124. Eurogentec Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Mouse Monoclonal Antibody Production Service Product Image Figure 2. Global Mouse Monoclonal Antibody Production Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mouse Monoclonal Antibody Production Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Mouse Monoclonal Antibody Production Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hybridoma Technology Image Figure 8. Phage Display Technology Image Figure 9. Single B Cell Cloning Technology Image Figure 10. Global Mouse Monoclonal Antibody Production Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Mouse Monoclonal Antibody Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Mouse Monoclonal Antibody Production Service Sales Value Share by Type (2021-2032) Figure 13. Biomedical Research Image Figure 14. Diagnostics Image Figure 15. Others Image Figure 16. Global Mouse Monoclonal Antibody Production Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Mouse Monoclonal Antibody Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Mouse Monoclonal Antibody Production Service Sales Value Share by Application (2021-2032) Figure 19. Global Mouse Monoclonal Antibody Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Mouse Monoclonal Antibody Production Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Mouse Monoclonal Antibody Production Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Mouse Monoclonal Antibody Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Mouse Monoclonal Antibody Production Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Mouse Monoclonal Antibody Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Mouse Monoclonal Antibody Production Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Mouse Monoclonal Antibody Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Mouse Monoclonal Antibody Production Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Mouse Monoclonal Antibody Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Mouse Monoclonal Antibody Production Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Mouse Monoclonal Antibody Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Hybridoma Technology
  • Phage Display Technology
  • Single B Cell Cloning Technology
Applications
  • Biomedical Research
  • Diagnostics
  • Others
Companies covered
  • Thermo Fisher Scientific
  • GenScript
  • Sino Biological
  • ProMab
  • Sydlabs
  • Rockland Immunochemicals, Inc
  • Boster Bio
  • Antibodies Incorporated
  • Creative Diagnostics
  • Synaptic Systems
  • Inotiv Bioproducts
  • ProSpec
  • Applied Biological Materials Inc. (abm)
  • Creative Biolabs
  • Abvigen
  • R&D Systems
  • Eurogentec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mouse Monoclonal Antibody Production Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mouse Monoclonal Antibody Production Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Mouse Monoclonal Antibody Production Service Market Dynamics
  1. 2.1 Mouse Monoclonal Antibody Production Service Industry Trends
  2. 2.2 Mouse Monoclonal Antibody Production Service Industry Drivers
  3. 2.3 Mouse Monoclonal Antibody Production Service Industry Opportunities and Challenges
  4. 2.4 Mouse Monoclonal Antibody Production Service Industry Restraints
3 Mouse Monoclonal Antibody Production Service Market by Company
  1. 3.1 Global Mouse Monoclonal Antibody Production Service Company Revenue Ranking in 2025
  2. 3.2 Global Mouse Monoclonal Antibody Production Service Revenue by Company (2021-2026)
  3. 3.3 Global Mouse Monoclonal Antibody Production Service Company Ranking (2024-2026)
  4. 3.4 Global Mouse Monoclonal Antibody Production Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Mouse Monoclonal Antibody Production Service Company Product Type and Application
  6. 3.6 Global Mouse Monoclonal Antibody Production Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Mouse Monoclonal Antibody Production Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Mouse Monoclonal Antibody Production Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Mouse Monoclonal Antibody Production Service Market by Type
  1. 4.1 Mouse Monoclonal Antibody Production Service Type Introduction
  2. 4.1.1 Hybridoma Technology
  3. 4.1.2 Phage Display Technology
  4. 4.1.3 Single B Cell Cloning Technology
  5. 4.2 Global Mouse Monoclonal Antibody Production Service Sales Value by Type
  6. 4.2.1 Global Mouse Monoclonal Antibody Production Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mouse Monoclonal Antibody Production Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Mouse Monoclonal Antibody Production Service Sales Value Share by Type (2021-2032)
5 Mouse Monoclonal Antibody Production Service Market by Application
  1. 5.1 Mouse Monoclonal Antibody Production Service Application Introduction
  2. 5.1.1 Biomedical Research
  3. 5.1.2 Diagnostics
  4. 5.1.3 Others
  5. 5.2 Global Mouse Monoclonal Antibody Production Service Sales Value by Application
  6. 5.2.1 Global Mouse Monoclonal Antibody Production Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mouse Monoclonal Antibody Production Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Mouse Monoclonal Antibody Production Service Sales Value Share by Application (2021-2032)
6 Mouse Monoclonal Antibody Production Service Regional Value Analysis
  1. 6.1 Global Mouse Monoclonal Antibody Production Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mouse Monoclonal Antibody Production Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Mouse Monoclonal Antibody Production Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Mouse Monoclonal Antibody Production Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mouse Monoclonal Antibody Production Service Sales Value (2021-2032)
  7. 6.3.2 North America Mouse Monoclonal Antibody Production Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Mouse Monoclonal Antibody Production Service Sales Value (2021-2032)
  10. 6.4.2 Europe Mouse Monoclonal Antibody Production Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Mouse Monoclonal Antibody Production Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Mouse Monoclonal Antibody Production Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Mouse Monoclonal Antibody Production Service Sales Value (2021-2032)
  16. 6.6.2 South America Mouse Monoclonal Antibody Production Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Mouse Monoclonal Antibody Production Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Mouse Monoclonal Antibody Production Service Sales Value Share by Country, 2025 VS 2032
7 Mouse Monoclonal Antibody Production Service Country-level Value Analysis
  1. 7.1 Global Mouse Monoclonal Antibody Production Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mouse Monoclonal Antibody Production Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Mouse Monoclonal Antibody Production Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Mouse Monoclonal Antibody Production Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Mouse Monoclonal Antibody Production Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Mouse Monoclonal Antibody Production Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Mouse Monoclonal Antibody Production Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Mouse Monoclonal Antibody Production Service Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 GenScript
  8. 8.2.1 GenScript Company Information
  9. 8.2.2 GenScript Business Overview
  10. 8.2.3 GenScript Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GenScript Mouse Monoclonal Antibody Production Service Product Portfolio
  12. 8.2.5 GenScript Recent Developments
  13. 8.3 Sino Biological
  14. 8.3.1 Sino Biological Company Information
  15. 8.3.2 Sino Biological Business Overview
  16. 8.3.3 Sino Biological Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sino Biological Mouse Monoclonal Antibody Production Service Product Portfolio
  18. 8.3.5 Sino Biological Recent Developments
  19. 8.4 ProMab
  20. 8.4.1 ProMab Company Information
  21. 8.4.2 ProMab Business Overview
  22. 8.4.3 ProMab Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ProMab Mouse Monoclonal Antibody Production Service Product Portfolio
  24. 8.4.5 ProMab Recent Developments
  25. 8.5 Sydlabs
  26. 8.5.1 Sydlabs Company Information
  27. 8.5.2 Sydlabs Business Overview
  28. 8.5.3 Sydlabs Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sydlabs Mouse Monoclonal Antibody Production Service Product Portfolio
  30. 8.5.5 Sydlabs Recent Developments
  31. 8.6 Rockland Immunochemicals, Inc
  32. 8.6.1 Rockland Immunochemicals, Inc Company Information
  33. 8.6.2 Rockland Immunochemicals, Inc Business Overview
  34. 8.6.3 Rockland Immunochemicals, Inc Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Rockland Immunochemicals, Inc Mouse Monoclonal Antibody Production Service Product Portfolio
  36. 8.6.5 Rockland Immunochemicals, Inc Recent Developments
  37. 8.7 Boster Bio
  38. 8.7.1 Boster Bio Company Information
  39. 8.7.2 Boster Bio Business Overview
  40. 8.7.3 Boster Bio Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Boster Bio Mouse Monoclonal Antibody Production Service Product Portfolio
  42. 8.7.5 Boster Bio Recent Developments
  43. 8.8 Antibodies Incorporated
  44. 8.8.1 Antibodies Incorporated Company Information
  45. 8.8.2 Antibodies Incorporated Business Overview
  46. 8.8.3 Antibodies Incorporated Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Antibodies Incorporated Mouse Monoclonal Antibody Production Service Product Portfolio
  48. 8.8.5 Antibodies Incorporated Recent Developments
  49. 8.9 Creative Diagnostics
  50. 8.9.1 Creative Diagnostics Company Information
  51. 8.9.2 Creative Diagnostics Business Overview
  52. 8.9.3 Creative Diagnostics Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Creative Diagnostics Mouse Monoclonal Antibody Production Service Product Portfolio
  54. 8.9.5 Creative Diagnostics Recent Developments
  55. 8.10 Synaptic Systems
  56. 8.10.1 Synaptic Systems Company Information
  57. 8.10.2 Synaptic Systems Business Overview
  58. 8.10.3 Synaptic Systems Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Synaptic Systems Mouse Monoclonal Antibody Production Service Product Portfolio
  60. 8.10.5 Synaptic Systems Recent Developments
  61. 8.11 Inotiv Bioproducts
  62. 8.11.1 Inotiv Bioproducts Company Information
  63. 8.11.2 Inotiv Bioproducts Business Overview
  64. 8.11.3 Inotiv Bioproducts Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Inotiv Bioproducts Mouse Monoclonal Antibody Production Service Product Portfolio
  66. 8.11.5 Inotiv Bioproducts Recent Developments
  67. 8.12 ProSpec
  68. 8.12.1 ProSpec Company Information
  69. 8.12.2 ProSpec Business Overview
  70. 8.12.3 ProSpec Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ProSpec Mouse Monoclonal Antibody Production Service Product Portfolio
  72. 8.12.5 ProSpec Recent Developments
  73. 8.13 Applied Biological Materials Inc. (abm)
  74. 8.13.1 Applied Biological Materials Inc. (abm) Company Information
  75. 8.13.2 Applied Biological Materials Inc. (abm) Business Overview
  76. 8.13.3 Applied Biological Materials Inc. (abm) Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Applied Biological Materials Inc. (abm) Mouse Monoclonal Antibody Production Service Product Portfolio
  78. 8.13.5 Applied Biological Materials Inc. (abm) Recent Developments
  79. 8.14 Creative Biolabs
  80. 8.14.1 Creative Biolabs Company Information
  81. 8.14.2 Creative Biolabs Business Overview
  82. 8.14.3 Creative Biolabs Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Creative Biolabs Mouse Monoclonal Antibody Production Service Product Portfolio
  84. 8.14.5 Creative Biolabs Recent Developments
  85. 8.15 Abvigen
  86. 8.15.1 Abvigen Company Information
  87. 8.15.2 Abvigen Business Overview
  88. 8.15.3 Abvigen Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Abvigen Mouse Monoclonal Antibody Production Service Product Portfolio
  90. 8.15.5 Abvigen Recent Developments
  91. 8.16 R&D Systems
  92. 8.16.1 R&D Systems Company Information
  93. 8.16.2 R&D Systems Business Overview
  94. 8.16.3 R&D Systems Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 R&D Systems Mouse Monoclonal Antibody Production Service Product Portfolio
  96. 8.16.5 R&D Systems Recent Developments
  97. 8.17 Eurogentec
  98. 8.17.1 Eurogentec Company Information
  99. 8.17.2 Eurogentec Business Overview
  100. 8.17.3 Eurogentec Mouse Monoclonal Antibody Production Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Eurogentec Mouse Monoclonal Antibody Production Service Product Portfolio
  102. 8.17.5 Eurogentec Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst